Prospective analysis of 18F-FDG PET/CT predictive value in patients with low rectal cancer treated with neoadjuvant chemoradiotherapy and conservative surgery.

Artor Niccoli-AsabellaCorinna AltiniRaffaele De LucaMargherita FanelliDomenico RubiniCosimo CaliandroSeverino MontemurroGiuseppe Rubini

Published in: BioMed research international (2014)

(18)F-FDG PET/CT can evaluate response to nCRT in LRC, even if more studies are required to define the most significant parameter for predicting pathologic tumor changes.

Keyphrases

rectal cancer
locally advanced
neoadjuvant chemotherapy
minimally invasive
coronary artery bypass
squamous cell carcinoma
case control
surgical site infection
radiation therapy
newly diagnosed
percutaneous coronary intervention
lymph node